CAR T cells for hematological malignancies

J Clin Invest. 2024 Jan 16;134(2):e177160. doi: 10.1172/JCI177160.

Authors

Barbara Savoldo^{1

2}, Natalie Grover^{1

3}, Gianpietro Dotti^{1

4}

Affiliations

¹ Lineberger Comprehensive Cancer Center.
² Department of Pediatrics.
³ Department of Medicine, and.
⁴ Department of Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

No abstract available

MeSH terms

Hematologic Neoplasms* / pathology
Hematologic Neoplasms* / therapy
Humans
Immunotherapy, Adoptive
Receptors, Chimeric Antigen* / genetics
T-Lymphocytes / pathology

Substances

Receptors, Chimeric Antigen